Breaking News

Canada's Consumer Price Index Rises a Less-Than-Forecast 2% in November
Tweet TWEET

Achillion to Present at the Credit Suisse Healthcare Conference

Achillion to Present at the Credit Suisse Healthcare Conference

NEW HAVEN, Conn., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals,
Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and
Chief Executive Officer of Achillion, will present a corporate overview at the
Credit Suisse Healthcare Conference on Wednesday, November 13, 2013 at 1:30
p.m. MT / 3:30 p.m. ET at The Phoenician Hotel in Scottsdale, AZ.

The live audio and subsequent archived webcasts of the Company's presentations
will be accessible from the Company's investor relations website,
http://ir.achillion.com. The audio recording will be archived for 30 days
following the live presentation. Please connect to Achillion's website several
minutes prior to the start of the presentation to ensure adequate time for any
software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing
important new treatments to patients with infectious disease. Achillion's
discovery, clinical development, and commercial teams have advanced multiple
novel product candidates with proven mechanisms of action into studies and
toward the market. Achillion is focused on solutions for the most challenging
problems in infectious disease including HCV and resistant bacterial
infections. For more information on Achillion Pharmaceuticals, please visit
www.achillion.com or call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 752-5510
         gschulman@achillion.com
        
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com

Achillion Pharmaceuticals logo
 
Press spacebar to pause and continue. Press esc to stop.